Details of the Drug

General Information of Drug (ID: DMRGFBU)

• Drug Name: CWP-231

Indication

Disease Entry	ICD 11	Status	REF
Solid tumour/cancer	2A00-2F9Z	Phase 1	[1]

• Cross-matching ID: TTD ID: D03NTF

References

• [1] ClinicalTrials.gov (NCT02426723) Clinical Study of CWP232291 in Relapsed or Refractory Myeloma Patients. U.S. National Institutes of Health.